Literature DB >> 28841445

APOBEC3B lysine residues are dispensable for DNA cytosine deamination, HIV-1 restriction, and nuclear localization.

Amy M Molan1, Heather M Hanson1, Cynthia M Chweya1, Brett D Anderson1, Gabriel J Starrett1, Christopher M Richards1, Reuben S Harris2.   

Abstract

The APOBEC3 DNA cytosine deaminase family comprises a fundamental arm of the innate immune response and is best known for retrovirus restriction. Several APOBEC3 enzymes restrict HIV-1 and related retroviruses by deaminating viral cDNA cytosines to uracils compromising viral genomes. Human APOBEC3B (A3B) shows strong virus restriction activities in a variety of experimental systems, and is subjected to tight post-translational regulation evidenced by cell-specific HIV-1 restriction activity and active nuclear import. Here we ask whether lysines and/or lysine post-translational modifications are required for these A3B activities. A lysine-free derivative of human A3B was constructed and shown to be indistinguishable from the wild-type enzyme in DNA cytosine deamination, HIV-1 restriction, and nuclear localization activities. However, lysine loss did render the protein resistant to degradation by SIV Vif. Taken together, we conclude that lysine side chains and modifications thereof are unlikely to be central to A3B function or regulation in human cells.
Copyright © 2017. Published by Elsevier Inc.

Entities:  

Keywords:  APOBEC3B; DNA deamination; HIV-1 restriction; Modification; Posttranslational; Vif

Mesh:

Substances:

Year:  2017        PMID: 28841445      PMCID: PMC5623654          DOI: 10.1016/j.virol.2017.08.025

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  45 in total

Review 1.  APOBECs and virus restriction.

Authors:  Reuben S Harris; Jaquelin P Dudley
Journal:  Virology       Date:  2015-03-26       Impact factor: 3.616

2.  Subcellular localization of the APOBEC3 proteins during mitosis and implications for genomic DNA deamination.

Authors:  Lela Lackey; Emily K Law; William L Brown; Reuben S Harris
Journal:  Cell Cycle       Date:  2013-02-06       Impact factor: 4.534

3.  Virology. Response to Comment on "Specific and nonhepatotoxic degradation of nuclear hepatitis B virus cccDNA".

Authors:  Yuchen Xia; Julie Lucifora; Florian Reisinger; Mathias Heikenwalder; Ulrike Protzer
Journal:  Science       Date:  2014-06-13       Impact factor: 47.728

4.  Methylcytosine and normal cytosine deamination by the foreign DNA restriction enzyme APOBEC3A.

Authors:  Michael A Carpenter; Ming Li; Anurag Rathore; Lela Lackey; Emily K Law; Allison M Land; Brandon Leonard; Shivender M D Shandilya; Markus-Frederik Bohn; Celia A Schiffer; William L Brown; Reuben S Harris
Journal:  J Biol Chem       Date:  2012-08-15       Impact factor: 5.157

5.  APOBEC3B is an enzymatic source of mutation in breast cancer.

Authors:  Michael B Burns; Lela Lackey; Michael A Carpenter; Anurag Rathore; Allison M Land; Brandon Leonard; Eric W Refsland; Delshanee Kotandeniya; Natalia Tretyakova; Jason B Nikas; Douglas Yee; Nuri A Temiz; Duncan E Donohue; Rebecca M McDougle; William L Brown; Emily K Law; Reuben S Harris
Journal:  Nature       Date:  2013-02-06       Impact factor: 49.962

6.  Enzymatically active APOBEC3G is required for efficient inhibition of human immunodeficiency virus type 1.

Authors:  Eri Miyagi; Sandrine Opi; Hiroaki Takeuchi; Mohammad Khan; Ritu Goila-Gaur; Sandra Kao; Klaus Strebel
Journal:  J Virol       Date:  2007-10-10       Impact factor: 5.103

7.  The APOBEC3B deletion polymorphism is associated with prevalence of hepatitis B virus, hepatitis C virus, Torque Teno virus, and Toxoplasma gondii co-infection among HIV-infected individuals.

Authors:  Afiono Agung Prasetyo; Ratna Sariyatun; Yulia Sari; Sri Haryati; Zainal Arifin Adnan; Seiji Kageyama
Journal:  J Clin Virol       Date:  2015-07-08       Impact factor: 3.168

8.  Crystal Structure of the DNA Deaminase APOBEC3B Catalytic Domain.

Authors:  Ke Shi; Michael A Carpenter; Kayo Kurahashi; Reuben S Harris; Hideki Aihara
Journal:  J Biol Chem       Date:  2015-09-28       Impact factor: 5.157

9.  Human papillomavirus E6 triggers upregulation of the antiviral and cancer genomic DNA deaminase APOBEC3B.

Authors:  Valdimara C Vieira; Brandon Leonard; Elizabeth A White; Gabriel J Starrett; Nuri A Temiz; Laurel D Lorenz; Denis Lee; Marcelo A Soares; Paul F Lambert; Peter M Howley; Reuben S Harris
Journal:  mBio       Date:  2014-12-23       Impact factor: 7.867

10.  The Phyre2 web portal for protein modeling, prediction and analysis.

Authors:  Lawrence A Kelley; Stefans Mezulis; Christopher M Yates; Mark N Wass; Michael J E Sternberg
Journal:  Nat Protoc       Date:  2015-05-07       Impact factor: 13.491

View more
  1 in total

1.  A Rabbit Monoclonal Antibody against the Antiviral and Cancer Genomic DNA Mutating Enzyme APOBEC3B.

Authors:  William L Brown; Emily K Law; Prokopios P Argyris; Michael A Carpenter; Rena Levin-Klein; Alison N Ranum; Amy M Molan; Colleen L Forster; Brett D Anderson; Lela Lackey; Reuben S Harris
Journal:  Antibodies (Basel)       Date:  2019-09-10
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.